|
|
原发性干燥综合征血清学标志物的研究进展
|
Abstract:
原发性干燥综合征(pSS)是一种独特的系统性的自身免疫性疾病，涉及唾液和泪腺以及多个其他器官系统的损伤，其与多种血清学标志物具有相关性，如抗SSA抗体、抗SSB抗体、抗Ro52抗体、抗着丝点抗体、抗M3R抗体、水通道蛋白5、抗唾液腺蛋白1抗体等。本文将对近年来血清学标志物在pSS疾病的发病机制、临床表现以及预后等方面的作用进行综述，旨在为临床实践和科学研究提供新的思路与研究方向。
Primary Sj？gren’s syndrome (pSS) is a unique systemic autoimmune disease involving damage to salivary and lacrimal glands, as well as multiple other organ systems, that is associated with multiple serological markers, such as anti-SSA antibodies, anti-SSB antibodies, anti-RO52 antibodies, anti-centromere antibodies, anti-M3R antibodies, aquaporin 5, anti-salivary gland protein 1 antibodies and so on. This article will review the recent serological markers in the pathogenesis, clinical manifestations and prognosis of pSS, aiming to provide new ideas and research directions for clinical practice and scientific research.
| [1] | Retamozo, S., Akasbi, M., Brito-Zerón, P., et al. (2012) Anti-Ro52 Antibody Testing Influences the Classification and Clinical Characterisation of Primary Sjgren’s Syndrome. Clinical & Experimental Rheumatology, 30, 686-692. |
| [2] | 刘荷江, 常娥, 郭敏. 自身抗体检测诊断原发性干燥综合征的临床应用价值分析[J]. 内科, 2018, 13(3): 329-332. |
| [3] | Hernández-Molina, G., Leal-Alegre, G. and Michel-Peregrina, M. (2011) The Meaning of Anti-Ro and Anti-La Antibodies in Primary Sjögren’s Syndrome. Autoimmunity Reviews, 10, 123-125. https://doi.org/10.1016/j.autrev.2010.09.001 |
| [4] | Routsias, J.G. and Tzioufas, A.G. (2010) Autoimmune Response and Target Autoantigens in Sjögren’s Syndrome. European Journal of Clinical Investigation, 40, 1026-1036. https://doi.org/10.1111/j.1365-2362.2010.02342.x |
| [5] | He, J., Fang, W. and Li, Z.G. (2008) [The Application of Combined Detection of Autoantibodies in Primary Sjögren’s Syndrome]. Chinese Journal of Internal Medicine, 47, 46-51. |
| [6] | Bournia, V. and Vlachoyiannopoulos, P.G. (2012) Subgroups of Sjögren Syndrome Patients According to Serological Profiles. Journal of Autoimmunity, 39, 15-26. https://doi.org/10.1016/j.jaut.2012.03.001 |
| [7] | Mofors, J., Holmqvist, M., Westermark, L., Björk, A., Kvarnström, M., Forsblad‐d’Elia, H., et al. (2019) Concomitant Ro/SSA and La/SSB Antibodies Are Biomarkers for the Risk of Venous Thromboembolism and Cerebral Infarction in Primary Sjögren’s Syndrome. Journal of Internal Medicine, 286, 458-468. https://doi.org/10.1111/joim.12941 |
| [8] | Mofors, J., Björk, A., Smedby, K.E., Kvarnström, M., Forsblad-d’Elia, H., Magnusson-Bucher, S., et al. (2020) Increased Risk of Multiple Myeloma in Primary Sjögren’s Syndrome Is Limited to Individuals with Ro/SSA and La/SSB Autoantibodies. Annals of the Rheumatic Diseases, 79, 307-308. https://doi.org/10.1136/annrheumdis-2019-216287 |
| [9] | Acar-Denizli, N., Horváth, I.F., Mandl, T., et al. (2020) Systemic Phenotype Related to Primary Sjgren’s Syndrome in 279 Patients Carrying Isolated Anti-La/SSB Antibodies. Clinical and Experimental Rheumatology, 126, 85-94. |
| [10] | Cafaro, G., Perricone, C., Baldini, C., et al. (2020) Significance of Anti-La/SSB Antibodies in Primary Sjögren’s Syndrome Patients with Combined Positivity for Anti-Ro/SSA and Salivary Gland Biopsy. Clinical and Experimental Rheumatology, 126, 53-56. |
| [11] | Quartuccio, L., Baldini, C., Bartoloni, E., Priori, R., Carubbi, F., Corazza, L., et al. (2015) Anti-SSA/SSB-Negative Sjögren’s Syndrome Shows a Lower Prevalence of Lymphoproliferative Manifestations, and a Lower Risk of Lymphoma Evolution. Autoimmunity Reviews, 14, 1019-1022. https://doi.org/10.1016/j.autrev.2015.07.002 |
| [12] | Maślińska, M., Mańczak, M., Wojciechowska, B. and Kwiatkowska, B. (2017) The Prevalence of ANA Antibodies, Anticentromere Antibodies, and Anti-Cyclic Citrullinated Peptide Antibodies in Patients with Primary Sjögren’s Syndrome Compared to Patients with Dryness Symptoms without Primary Sjögren’s Syndrome Confirmation. Rheumatology, 55, 113-119. https://doi.org/10.5114/reum.2017.68909 |
| [13] | Wainwright, B., Bhan, R., Trad, C., Cohen, R., Saxena, A., Buyon, J., et al. (2020) Autoimmune-Mediated Congenital Heart Block. Best Practice & Research Clinical Obstetrics & Gynaecology, 64, 41-51. https://doi.org/10.1016/j.bpobgyn.2019.09.001 |
| [14] | Ambrosi, A., Dzikaite, V., Park, J., Strandberg, L., Kuchroo, V.K., Herlenius, E., et al. (2012) Anti-Ro52 Monoclonal Antibodies Specific for Amino Acid 200-239, but Not Other Ro52 Epitopes, Induce Congenital Heart Block in a Rat Model. Annals of the Rheumatic Diseases, 71, 448-454. https://doi.org/10.1136/annrheumdis-2011-200414 |
| [15] | Llanos, C., Friedman, D.M., Saxena, A., Izmirly, P.M., Tseng, C., Dische, R., et al. (2012) Anatomical and Pathological Findings in Hearts from Fetuses and Infants with Cardiac Manifestations of Neonatal Lupus. Rheumatology, 51, 1086-1092. https://doi.org/10.1093/rheumatology/ker515 |
| [16] | Cuneo, B.F., Strasburger, J.F., Niksch, A., Ovadia, M. and Wakai, R.T. (2009) An Expanded Phenotype of Maternal SSA/SSB Antibody-Associated Fetal Cardiac Disease. The Journal of Maternal-Fetal & Neonatal Medicine, 22, 233-238. https://doi.org/10.1080/14767050802488220 |
| [17] | Lin, L., Hang, H., Zhang, J., Lu, J., Chen, D. and Shi, J. (2022) Clinical Significance of Anti-SSA/Ro Antibody in Neuromyelitis Optica Spectrum Disorders. Multiple Sclerosis and Related Disorders, 58, Article ID: 103494. https://doi.org/10.1016/j.msard.2022.103494 |
| [18] | Estiasari, R., Matsushita, T., Masaki, K., Akiyama, T., Yonekawa, T., Isobe, N., et al. (2012) Comparison of Clinical, Immunological and Neuroimaging Features between Anti-Aquaporin-4 Antibody-Positive and Antibody-Negative Sjögren’s Syndrome Patients with Central Nervous System Manifestations. Multiple Sclerosis Journal, 18, 807-816. https://doi.org/10.1177/1352458511431727 |
| [19] | Tani, J., Liao, H., Hsu, H., Chen, L., Chang, T., Shin‐Yi Lin, C., et al. (2020) Immune‐Mediated Axonal Dysfunction in Seropositive and Seronegative Primary Sjögren’s Syndrome. Annals of Clinical and Translational Neurology, 7, 819-828. https://doi.org/10.1002/acn3.51053 |
| [20] | Lisi, S., Sisto, M., Lofrumento, D.D. and D’Amore, M. (2012) Sjögren’s Syndrome Autoantibodies Provoke Changes in Gene Expression Profiles of Inflammatory Cytokines Triggering a Pathway Involving TACE/NF-κB. Laboratory Investigation, 92, 615-624. https://doi.org/10.1038/labinvest.2011.190 |
| [21] | Ben-Chetrit, E., Chan, E.K., Sullivan, K.F. and Tan, E.M. (1988) A 52-Kd Protein Is a Novel Component of the SSA/Ro Antigenic Particle. The Journal of experimental medicine, 167, 1560-1571. https://doi.org/10.1084/jem.167.5.1560 |
| [22] | Peene, I., Meheus, L., De Keyser, S., Humbel, R., Veys, E.M. and De Keyser, F. (2002) Anti-Ro52 Reactivity Is an Independent and Additional Serum Marker in Connective Tissue Disease. Annals of the Rheumatic Diseases, 61, 929-933. https://doi.org/10.1136/ard.61.10.929 |
| [23] | Brauner, S., Ivanchenko, M., Thorlacius, G.E., Ambrosi, A. and Wahren-Herlenius, M. (2018) The Sjögren’s Syndrome-Associated Autoantigen Ro52/TRIM21 Modulates Follicular B Cell Homeostasis and Immunoglobulin Production. Clinical and Experimental Immunology, 194, 315-326. https://doi.org/10.1111/cei.13211 |
| [24] | Espinosa, A., Zhou, W., Ek, M., Hedlund, M., Brauner, S., Popovic, K., et al. (2006) The Sjögren’s Syndrome-Associated Autoantigen Ro52 Is an E3 Ligase That Regulates Proliferation and Cell Death. The Journal of Immunology, 176, 6277-6285. https://doi.org/10.4049/jimmunol.176.10.6277 |
| [25] | Oke, V., Vassilaki, I., Espinosa, A., Strandberg, L., Kuchroo, V.K., Nyberg, F., et al. (2009) High Ro52 Expression in Spontaneous and UV-Induced Cutaneous Inflammation. Journal of Investigative Dermatology, 129, 2000-2010. https://doi.org/10.1038/jid.2008.453 |
| [26] | Chan, E.K.L. (2022) Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome When Associated with Interstitial Lung Disease in Systemic Sclerosis and Autoimmune Myositis. Clinical Reviews in Allergy & Immunology, 63, 178-193. https://doi.org/10.1007/s12016-021-08911-z |
| [27] | Decker, P., Moulinet, T., Pontille, F., Cravat, M., De Carvalho Bittencourt, M. and Jaussaud, R. (2022) An Updated Review of Anti-Ro52 (TRIM21) Antibodies Impact in Connective Tissue Diseases Clinical Management. Autoimmunity Reviews, 21, Article ID: 103013. https://doi.org/10.1016/j.autrev.2021.103013 |
| [28] | Buvry, C., Cassagnes, L., Tekath, M., Artigues, M., Pereira, B., Rieu, V., et al. (2020) Anti-Ro52 Antibodies Are a Risk Factor for Interstitial Lung Disease in Primary Sjögren Syndrome. Respiratory Medicine, 163, Article ID: 105895. https://doi.org/10.1016/j.rmed.2020.105895 |
| [29] | Lin, W., Xin, Z., Zhang, J., Liu, N., Ren, X., Liu, M., et al. (2022) Interstitial Lung Disease in Primary Sjögren’s Syndrome. BMC Pulmonary Medicine, 22, Article No. 73. https://doi.org/10.1186/s12890-022-01868-5 |
| [30] | Palm, O., Garen, T., Berge Enger, T., Jensen, J.L., Lund, M., Aalokken, T.M., et al. (2012) Clinical Pulmonary Involvement in Primary Sjögren’s Syndrome: Prevalence, Quality of Life and Mortality—A Retrospective Study Based on Registry Data. Rheumatology, 52, 173-179. https://doi.org/10.1093/rheumatology/kes311 |
| [31] | Tzioufas, A.G., Wassmuth, R., Dafni, U.G., Guialis, A., Haga, H., Isenberg, D.A., et al. (2002) Clinical, Immunological, and Immunogenetic Aspects of Autoantibody Production against Ro/SSA, La/SSB and Their Linear Epitopes in Primary Sjögren’s Syndrome (PSS): A European Multicentre Study. Annals of the Rheumatic Diseases, 61, 398-404. https://doi.org/10.1136/ard.61.5.398 |
| [32] | Li, B. (2015) Autoantibodies in Chinese Patients with Chronic Hepatitis B: Prevalence and Clinical Associations. World Journal of Gastroenterology, 21, 283-291. https://doi.org/10.3748/wjg.v21.i1.283 |
| [33] | Jordà, F.D., Ginestar, J.F., Balén, M.B., Cortés, J.O., Hariri, A.B., Ñíguez, J.A.R., et al. (2003) Hepatitis autoinmune y anticuerpos anti-Ro positivos. ¿Alguna relación? Gastroenterología y Hepatología, 26, 475-479. https://doi.org/10.1016/s0210-5705(03)70397-5 |
| [34] | Tan, E.M., Rodnan, G.P., Garcia, I., Moroi, Y., Fritzler, M.J. and Peebles, C. (1980) Diversity of Antinuclear Antibodies in Progressive Systemic Sclerosis. Arthritis & Rheumatism, 23, 617-625. https://doi.org/10.1002/art.1780230602 |
| [35] | Baer, A.N., Medrano, L., McAdams‐DeMarco, M. and Gniadek, T.J. (2016) Association of Anticentromere Antibodies with More Severe Exocrine Glandular Dysfunction in Sjögren’s Syndrome: Analysis of the Sjögren’s International Collaborative Clinical Alliance Cohort. Arthritis Care & Research, 68, 1554-1559. https://doi.org/10.1002/acr.22859 |
| [36] | Nakamura, H., Kawakami, A., Hayashi, T., Iwamoto, N., Okada, A., Tamai, M., et al. (2010) Anti-Centromere Antibody-Seropositive Sjögren’s Syndrome Differs from Conventional Subgroup in Clinical and Pathological Study. BMC Musculoskeletal Disorders, 11, Article No. 140. https://doi.org/10.1186/1471-2474-11-140 |
| [37] | Gulati, D., Kushner, I., File, E. and Magrey, M. (2010) Primary Sjögren’s Syndrome with Anticentromere Antibodies—A Clinically Distinct Subset. Clinical Rheumatology, 29, 789-791. https://doi.org/10.1007/s10067-009-1359-9 |
| [38] | Sumida, T., Iizuka, M., Asashima, H., Tsuboi, H. and Matsumoto, I. (2012) Pathogenic Role of Anti-M3 Muscarinic Acetylcholine Receptor Immune Response in Sjögren’s Syndrome. La Presse Médicale, 41, e461-e466. https://doi.org/10.1016/j.lpm.2012.05.019 |
| [39] | Iizuka, M., Wakamatsu, E., Tsuboi, H., Nakamura, Y., Hayashi, T., Matsui, M., et al. (2010) Pathogenic Role of Immune Response to M3 Muscarinic Acetylcholine Receptor in Sjögren’s Syndrome-Like Sialoadenitis. Journal of Autoimmunity, 35, 383-389. https://doi.org/10.1016/j.jaut.2010.08.004 |
| [40] | Jayakanthan, K., Ramya, J., Mandal, S.K., Sandhya, P., Gowri, M. and Danda, D. (2016) Younger Patients with Primary Sjögren’s Syndrome Are More Likely to Have Salivary Igg Anti-Muscarinic Acetylcholine Receptor Type 3 Antibodies. Clinical Rheumatology, 35, 657-662. https://doi.org/10.1007/s10067-016-3186-0 |
| [41] | He, J., Guo, J., Ding, Y., Li, Y., Pan, S., Liu, Y., et al. (2011) Diagnostic Significance of Measuring Antibodies to Cyclic Type 3 Muscarinic Acetylcholine Receptor Peptides in Primary Sjögren’s Syndrome. Rheumatology, 50, 879-884. https://doi.org/10.1093/rheumatology/keq420 |
| [42] | Kovács, L., Marczinovits, I., György, A., Tóth, G.K., Dorgai, L., Pál, J., et al. (2005) Clinical Associations of Autoantibodies to Human Muscarinic Acetylcholine Receptor 3213-228 in Primary Sjögren’s Syndrome. Rheumatology, 44, 1021-1025. https://doi.org/10.1093/rheumatology/keh672 |
| [43] | Magouliotis, D.E., Tasiopoulou, V.S., Svokos, A.A. and Svokos, K.A. (2020) Aquaporins in Health and Disease. Advances in Clinical Chemistry, 98, 149-171. https://doi.org/10.1016/bs.acc.2020.02.005 |
| [44] | Pust, A., Kylies, D., Hube-Magg, C., Kluth, M., Minner, S., Koop, C., et al. (2016) Aquaporin 5 Expression Is Frequent in Prostate Cancer and Shows a Dichotomous Correlation with Tumor Phenotype and PSA Recurrence. Human Pathology, 48, 102-110. https://doi.org/10.1016/j.humpath.2015.09.026 |
| [45] | Alam, J., Koh, J.H., Kim, N., Kwok, S., Park, S., Song, Y.W., et al. (2016) Detection of Autoantibodies against Aquaporin-5 in the Sera of Patients with Primary Sjögren’s Syndrome. Immunologic Research, 64, 848-856. https://doi.org/10.1007/s12026-016-8786-x |
| [46] | 罗慧臣, 李萍, 肖卫国. M3R与AQP5在干燥综合征患者唇腺中的表达与意义[J]. 中国免疫学杂志, 2011, 27(1): 79-81, 87. |
| [47] | Ma, T., Song, Y., Gillespie, A., Carlson, E.J., Epstein, C.J. and Verkman, A.S. (1999) Defective Secretion of Saliva in Transgenic Mice Lacking Aquaporin-5 Water Channels. Journal of Biological Chemistry, 274, 20071-20074. https://doi.org/10.1074/jbc.274.29.20071 |
| [48] | Soyfoo, M., Konno, A., Bolaky, N., Oak, J., Fruman, D., Nicaise, C., et al. (2012) Link between Inflammation and Aquaporin‐5 Distribution in Submandibular Gland in Sjögren’s Syndrome? Oral Diseases, 18, 568-574. https://doi.org/10.1111/j.1601-0825.2012.01909.x |
| [49] | Shen, L., Suresh, L., Lindemann, M., Xuan, J., Kowal, P., Malyavantham, K., et al. (2012) Novel autoantibodies in Sjögren’s syndrome. Clinical Immunology, 145, 251-255. https://doi.org/10.1016/j.clim.2012.09.013 |
| [50] | De Langhe, E., Bossuyt, X., Shen, L., Malyavantham, K., Ambrus, J.L. and Suresh, L. (2017) Evaluation of Autoantibodies in Patients with Primary and Secondary Sjögren’s Syndrome. The Open Rheumatology Journal, 11, 10-15. https://doi.org/10.2174/1874312901711010010 |
| [51] | 李子轲. SP1在干燥综合征中的作用的研究[D]: [硕士学位论文]. 武汉: 华中科技大学, 2021. |
| [52] | Suresh, L., Malyavantham, K., Shen, L. and Ambrus, J.L. (2015) Investigation of Novel Autoantibodies in Sjögren’s Syndrome Utilizing Sera from the Sjögren’s International Collaborative Clinical Alliance Cohort. BMC Ophthalmology, 15, Article No. 38. https://doi.org/10.1186/s12886-015-0023-1 |
| [53] | Shen, L., Kapsogeorgou, E.K., Yu, M., Suresh, L., Malyavantham, K., Tzioufas, A.G., et al. (2014) Evaluation of Salivary Gland Protein 1 Antibodies in Patients with Primary and Secondary Sjögren’s Syndrome. Clinical Immunology, 155, 42-46. https://doi.org/10.1016/j.clim.2014.08.009 |
